RxDoctor Payments Data

Alexei Shvilkin, MD

Clinical Cardiac Electrophysiology · South Weymouth, MANPI 1336107390

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $28,237 of the $34,586 with a category attached, or 81.6%. Biosense Webster, Inc. accounts for 82.0% of it on its own, with 4 other manufacturers making up the rest.

$34,586in general payments, 2019–2025

Across 90 payments — averaging $384.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biosense Webster, Inc.$28K
  • Medtronic$4K
  • Abbott$2K
  • Boston Scientific$736
  • Edwards Lifesciences$54
$3,391,044in research payments, 2019–2025

Across 150 payments — averaging $22,607 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$3.4M

What the payments were for

  • Consulting fees$28,23782%
  • Speaking & faculty fees$3,60010%
  • Travel & lodging$1,2754%
  • Food & beverage$1,4674%
  • Education$80%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Biosense Webster, Inc.55$28,374
Medtronic(2 entities)5$3,648
Abbott21$1,775
Boston Scientific7$736
Edwards Lifesciences2$54

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$34,586 in reported general payments places this provider in the 70th percentile of 106 clinical cardiac electrophysiology providers in Massachusetts.

See all clinical cardiac electrophysiology providers in Massachusetts

Medicare billing

Part B allowed, 2024
$218,729
Medicare patients
976
Services billed
3,080

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban331$439,081
XareltoRivaroxaban130$147,373
JardianceEmpagliflozin47$67,227
EntrestoSacubitril/Valsartan40$58,720
Flecainide Acetate188$8,934
Metoprolol Succinate246$3,999
Amiodarone Hcl85$1,788
Spironolactone169$1,527
Ezetimibe17$907
Atorvastatin Calcium59$778
Losartan Potassium49$642
Digoxin24$604
Lisinopril51$444
Amlodipine Besylate58$402
ClopidogrelClopidogrel Bisulfate13$284

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in South Weymouth

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →